Damian Brett Van Rossum

Title: Damian Brett Van Rossum: Innovator in Gastrointestinal and Cancer Research

Introduction

Damian Brett Van Rossum is a notable inventor based in State College, PA (US). He has made significant contributions to the fields of gastrointestinal disease treatment and cancer research. With a total of two patents to his name, his work focuses on innovative solutions that address critical health issues.

Latest Patents

Van Rossum's latest patents include a synthetic peptide modeled on the IRCX binding area of NHE3. This peptide acts as a competitive inhibitor of the IRCX, stimulating basal NHE3 activity while preventing elevated calcium and cAMP inhibition of NHE3. The methods of its preparation and use are aimed at preventing and treating gastrointestinal diseases, such as diarrhea. Another patent involves the regulation of cell survival by HSP90 and IP6K2. This patent identifies anti-cancer drugs by screening for agents and compounds that inhibit the binding of HSP90 and IP6K2. In vitro and in vivo assays can be utilized to monitor various phenomena associated with this binding or inhibition, including cell death and catalytic activity of IP6K2.

Career Highlights

Throughout his career, Van Rossum has worked with prestigious institutions such as The Johns Hopkins University and The Penn State Research Foundation. His research has contributed to advancements in understanding and treating complex health conditions.

Collaborations

Some of his notable coworkers include Randen Patterson and Mark Donowitz. Their collaborative efforts have furthered the impact of Van Rossum's research in the scientific community.

Conclusion

Damian Brett Van Rossum is a distinguished inventor whose work in gastrointestinal and cancer research has led to innovative patents that hold promise for future medical advancements. His contributions continue to influence the fields of health and medicine.